• Ameln H., Ameln H., Gustafsson T., Sundberg C. J., Okamoto K., Jansson E., Poellinger L. and Makino Y. (2005) Physiological activation of hypoxia inducible factor-1 in human skeletal muscle. FASEB J. 19, 10091011.
  • Bishop G. M. and Robinson S. R. (2004) Physiological roles of amyloid-beta and implications for its removal in Alzheimer's disease. Drugs Aging 21, 621630.
  • Correia S. C., Cardoso S., Santos R. X., Carvalho C., Santos M. S., Perry G., Smith M. A. and Moreira P. I. (2011) New insights into the mechanisms of mitochondrial preconditioning-triggered neuroprotection. Curr. Pharm. Des. 17, 33813389.
  • Correia S. C., Santos R. X., Cardoso S. M., Santos M. S., Oliveira C. R. and Moreira P. I. (2012) Cyanide preconditioning protects brain endothelial and NT2 neuron-like cells against glucotoxicity: role of mitochondrial reactive oxygen species and HIF-1α. Neurobiol. Dis. 45, 206218.
  • Correia S. C., Carvalho C., Cardoso S., Santos R. X., Plácido A. I., Candeias E., Duarte A. I. and Moreira P. I. (2013) Defective HIF signaling pathway and brain response to hypoxia in neurodegenerative diseases: not an “Iffy” question! Curr. Pharm. Des. [Epub ahead of print].
  • Lezi E., Lu J., Selfridge J. E., Burns J. M. and Swerdlow R. H. (2013) Lactate administration reproduces specific brain and liver exercise-related changes. J. Neurochem. (in press).
  • O'Hagan K. A., Cocchiglia S., Zhdanov A. V., et al. (2009) PGC-1alpha is coupled to HIF-1alpha-dependent gene expression by increasing mitochondrial oxygen consumption in skeletal muscle cells. Proc. Natl. Acad. Sci. USA 106, 21882193.
  • De Saedeleer C. J., Copetti T., Porporato P. E., Verrax J., Feron O. and Sonveaux P. (2012) Lactate activates HIF-1 in oxidative but not in Warburg-phenotype human tumor cells. PLoS ONE 7, e46571.
  • Soucek T., Cumming R., Dargusch R., Maher P. and Schubert D. (2003) The regulation of glucose metabolism by HIF-1 mediates a neuroprotective response to amyloid β peptide. Neuron 39, 4356.